Eric A Finkelstein entered the industry of Commercial Medical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Eric A Finkelstein by calling No number given during business hours. You can also write to the business’ Single Location at 104 Parkridge Avenue, Chapel Hill, North Carolina NC 27517. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Eric A Finkelstein |
| Representative: | Eric A Finkelstein |
| Place of Business: | 104 Parkridge Avenue, Chapel Hill, NC 27517 |
| Contact Number: | No number given |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2004 |
| Income/Year: | $0 to $49.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Eric A Finkelstein is a company operating from Orange, North Carolina providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Eric A Finkelstein has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Eric A Finkelstein at No number given for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 104 Parkridge Avenue in Chapel Hill, North Carolina 27517 and can be engaged online through the company website at , the company Twitter , and Facebook page .